4.8 Article

A large fraction of HLA class I ligands are proteasome-generated spliced peptides

期刊

SCIENCE
卷 354, 期 6310, 页码 354-358

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aaf4384

关键词

-

资金

  1. Berlin Institute of Health [CRG1-TP1]
  2. Einstein Stiftung Berlin grant [A2013-174]
  3. NC3Rs through David Sainsbury Fellowship [NC/K001949/1]
  4. BBSRC [BB/G007934/1]
  5. HFSP [RGP0061/2011]
  6. Leverhulme Trust [F/07058/BP]
  7. Royal Society through a Wolfson Research Merit Award
  8. Proteins@Work [184.032.201]
  9. Gravity Program Institute for Chemical Immunology
  10. Netherlands Organisation for Scientific Research
  11. BBSRC [BB/G007934/1, BB/K017284/1, BB/L023776/1] Funding Source: UKRI
  12. Biotechnology and Biological Sciences Research Council [BB/L023776/1, BB/G007934/1, BB/K017284/1] Funding Source: researchfish
  13. National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [NC/K001949/1] Funding Source: researchfish

向作者/读者索取更多资源

The proteasome generates the epitopes presented on human leukocyte antigen (HLA) class I molecules that elicit CD8(+) T cell responses. Reports of proteasome-generated spliced epitopes exist, but they have been regarded as rare events. Here, however, we show that the proteasome-generated spliced peptide pool accounts for one-third of the entire HLA class I immunopeptidome in terms of diversity and one-fourth in terms of abundance. This pool also represents a unique set of antigens, possessing particular and distinguishing features. We validated this observation using a range of complementary experimental and bioinformatics approaches, as well as multiple cell types. The widespread appearance and abundance of proteasome-catalyzed peptide splicing events has implications for immunobiology and autoimmunity theories and may provide a previously untapped source of epitopes for use in vaccines and cancer immunotherapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据